As people age, the skin loses collagen and elastin. These are two proteins that give the skin its strength and elasticity. When they decline, the skin becomes thinner, looser, and more prone to wrinkles and folds. Dermal fillers are a type of cosmetic procedure that can be used to restore lost volume in the skin. They are injected into the skin, and they can help to fill in wrinkles, folds, and other signs of aging. Dermal fillers are a safe and effective way to improve the appearance of the skin. They are FDA-approved, and they have been used by millions of people around the world.
Access Full Report at https://www.databridgemarketresearch.com/es/reports/global-dermal-fillers-market
Data Bridge Market Research analyses that the Dermal Fillers Market, which was USD 4,661.92 million in 2021, is expected to reach USD 10,666.40 million by 2029, at a CAGR of 10.90% during the forecast period of 2022-2029. There is increasing awareness of cosmetic procedures, and this is also driving the dermal fillers market. More people are now aware of the benefits of dermal fillers, and they are more likely to consider these procedures as a way to improve their appearance. Celebrity endorsements can also help to drive the market for dermal fillers. When celebrities endorse dermal fillers, it can help to raise awareness of these procedures and make them more appealing to a wider range of people.
Growing demand for non-surgical procedures is expected to drive the market's growth rate
There is a growing demand for non-surgical procedures, and this is also driving the dermal fillers market. Dermal fillers are a non-surgical procedure, and they are a safe and effective way to improve the appearance of the skin. This makes them an attractive option for people who are looking for a more natural-looking alternative to surgery. There have been significant improvements in dermal filler technology in recent years. This has made dermal fillers safer and more effective, and it has also made them more affordable. These improvements have made dermal fillers more appealing to a wider range of people, and they have also helped to drive the growth of the market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014- 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Suneva Medical inc (U.S.), Sinclair (U.S.), Revance (U.S.), BioPlus Co., Ltd. (South Korea), Zhejiang Jingjia Medical Technology Co.,Ltd. (China), Galderma Laboratories (U.S.), Merz North America, Inc (U.S.), Prollenium Medical Technologies (Canada), Contura International Ltd (Denmark), FillMed Laboratories (France), Anika Therapeutics, Inc (U,S.), Ipsen Pharma (France), BIOXIS Pharmaceuticals (U.S.), Zimmer Aesthetic (Germany), Teoxane (Switzerland), Amalian (U.S.), Givaudan (Switzerland), DSM (Netherlands), IBSA Nordic ApS (Denmark)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global dermal fillers market is categorized into seven notable segments based on type, product type, material type, drug type, application, end user and distribution channel.
- On the basis of type, the market is segmented into semi-permanent dermal filler, permanent dermal filler.
The semi-permanent dermal fillers segment of type segment is anticipated to dominate the dermal fillers market
The semi-permanent dermal fillers segment is expected to dominate the global dermal fillers market with 96.7% market share as they are widely used in facial line improvement, wrinkles and lip enhancement application areas among others because of less side effects, long lasting and bio-absorbent properties.
- On the basis of product type, the market is segmented into biodegradable dermal fillers, non-biodegradable dermal fillers.
The biodegradable dermal fillers segment of type segment is anticipated to dominate the dermal fillers market
The biodegradable dermal fillers segment is expected to dominate the global dermal fillers market with 80.5% market share as these are more preferred over the non-biodegradable fillers due to the safety concern.
- On the basis of material type, the market is segmented into natural dermal fillers and synthetic dermal fillers. The natural dermal fillers segment is expected to dominate the global dermal fillers market with 80.3% market share because of their high compatibility with human body, have few possibilities of allergic reaction and side effects that can be easily removed after filler removal procedures.
- On the basis of drug type, the market is segmented into branded, generic. The natural dermal fillers segment is expected to dominate the global dermal fillers market with 92.9% market share as extremely competitive markets are hindering the generic version of drugs from developing and physicians prescribes the branded drugs owing to high incentives of the product
- On the basis of application, the market is segmented into facial line correction, face lift, scar treatment, lip enhancement, wrinkles, sagging skin, rhinoplasty, cheek depression, dentistry, reconstructive surgery, aesthetic restoration, others. The facial line correction segment is expected to dominate the global dermal fillers market with 32.4% market share due to higher process volume than other application
- On the basis of end user, the market is segmented into dermatology clinics, ambulatory surgical centers, hospitals and others. The dermatology clinics segment is expected to dominate the global dermal fillers market with 73.4% market share as redundant aesthetic procedures are performed in dermatology clinics at most healthcare facilities
- On the basis of distribution channel, the market is segmented into retail pharmacy, drug stores, and online pharmacies. The drug stores segment is expected to dominate the global dermal fillers market with 82.8% market share due to easy accessibility than the other distribution channels and more number of drugs is procured in direct and bulk form.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Suneva Medical inc (U.S.), Sinclair (U.S.), Revance (U.S.), BioPlus Co., Ltd. (South Korea), Zhejiang Jingjia Medical Technology Co.,Ltd. (China), Galderma Laboratories (U.S.), Merz North America, Inc (U.S.), Prollenium Medical Technologies (Canada), Contura International Ltd (Denmark), FillMed Laboratories (France), Anika Therapeutics, Inc (U,S.), Ipsen Pharma (France), BIOXIS Pharmaceuticals (U.S.), Zimmer Aesthetic (Germany), Teoxane (Switzerland), Amalian (U.S.), Givaudan (Switzerland), DSM (Netherlands), IBSA Nordic ApS (Denmark).
Market Development
- In 2021, Galderma stated in that it had inked an agreement to acquire ALASTIN Skincare, Inc. This speciality aesthetics company's primary goal is to create clinically tested physician-dispensed skincare products. This transaction is subject to all regulatory approvals as well as typical closing conditions.
- In 2020, Allergan Aesthetics, an AbbVie company, stated in that it has signed a partnership with Luminera, an Israeli privately held aesthetics company. Allergan Aesthetics has purchased Luminera's entire dermal filler R&D pipeline and portfolio as part of this arrangement, expanding its dermal filler portfolio.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the dermal fillers market during the forecast period 2022-2029
North America is expected to continue to dominate the market during the forecast period, owing to the high demand for aesthetic procedures in the region. The increasing geriatric population in North America is also expected to drive the market growth.
Asia-Pacific is estimated to be the fastest growing region in the dermal fillers market in the forecast period 2022-2029
The Asia-Pacific dermal fillers market is expected to be the fastest-growing market during the forecast period, owing to the rising awareness about aesthetic procedures and the increasing disposable income in the region. The growing popularity of minimally invasive cosmetic procedures is also expected to drive the market growth in Asia-Pacific.
For more detailed information about the dermal fillers market report, click here – https://www.databridgemarketresearch.com/es/reports/global-dermal-fillers-market
